Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Pharmacogenetics|October 1, 1991
Mephenytoin phenotyping: lack of haematologic effect and timing of urine collectionsM V Relling, D Ayers, R L Heideman
Advances in Experimental Medicine and Biology|September 29, 1999
Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinicW E Evans, C H Pui, M V Relling
Clinical Pharmacology and Therapeutics|April 20, 2013
Clinical implementation of pharmacogenetics: more than one gene at a timeJ A Johnson, T E Klein, M V Relling
Journal of Chromatography. B, Biomedical Sciences and Applications|July 16, 1999
Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detectionX Cai, M H Woo, M J Edick, et al.
Pharmacotherapy|September 1, 1996
CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosisJ A Bosso, Q Liu, W E Evans, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphismT S Jones, W Yang, W E Evans, et al.
Blood|September 15, 1996
Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cellsC L Chen, J C Fuscoe, Q Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamilyM V Relling, T Aoyama, F J Gonzalez, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Human cytochrome P450 metabolism of teniposide and etoposideM V Relling, R Evans, C Dass, et al.
Cancer Research|January 1, 1989
Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomesM V Relling, W E Evans, R Fonné-Pfister, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Pharmacogenetics|October 1, 1991
Mephenytoin phenotyping: lack of haematologic effect and timing of urine collectionsM V Relling, D Ayers, R L Heideman
Advances in Experimental Medicine and Biology|September 29, 1999
Defining the optimal dosage of methotrexate for childhood acute lymphoblastic leukemia. New insights from the lab and clinicW E Evans, C H Pui, M V Relling
Clinical Pharmacology and Therapeutics|April 20, 2013
Clinical implementation of pharmacogenetics: more than one gene at a timeJ A Johnson, T E Klein, M V Relling
Journal of Chromatography. B, Biomedical Sciences and Applications|July 16, 1999
Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detectionX Cai, M H Woo, M J Edick, et al.
Pharmacotherapy|September 1, 1996
CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosisJ A Bosso, Q Liu, W E Evans, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphismT S Jones, W Yang, W E Evans, et al.
Blood|September 15, 1996
Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cellsC L Chen, J C Fuscoe, Q Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamilyM V Relling, T Aoyama, F J Gonzalez, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Human cytochrome P450 metabolism of teniposide and etoposideM V Relling, R Evans, C Dass, et al.
Cancer Research|January 1, 1989
Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomesM V Relling, W E Evans, R Fonné-Pfister, et al.
Pageof 18